The Mission: Science Meets Hope

Our Approach to Chronic TBI

For those in the chronic phase of TBI, the medical world has often offered little more than adaptation. Our mission is to change that. We support the creation of new pharmacologic treatments designed to:

• Promote Neural Cell Regeneration: Growing back what was lost.
• Renew Synaptic Plasticity: Re-wiring the brain’s ability to learn and move.
• Enable Axonal Regrowth: Restoring the "cables" that carry information through the CNS.
  

How Your Donation Works (The DLF Strategy)

From the DLF Scientific Blueprint:

• Convening Minds: We bring together leading bioscientists to collaborate on coordinated, programmatic research plans.
• Targeted Funding: We raise and distribute funds through a rigorous peer-review process, ensuring every dollar supports the most promising genomic and small-molecule medicines.
• Innovative Partnerships: We bridge the gap between academic research and biotechnology to explore cutting-edge solutions like Anti-sense Oligonucleotides (ASOs).
• Information & Advocacy: We provide a vital link for families and neuroscientists, sharing references, professional linkages, and the latest research news.
  

The Human Element

Inspired by Dan’s Journey

Dan Lewis suffered a traumatic brain injury in 2007. His journey is the heartbeat of this foundation. We aren't just funding labs; we are fighting for the thousands of families navigating the same path, seeking a future where "permanent damage" is a thing of the past.

$50

Supports research collaboration

$100

Funds genomic modeling tools

$500

Supports a DLF Prize/Fellowship